Bill · H.Res. 928· House(119-HRES-928)
Affirming support for most-favored-Nation drug pricing for United States patients.
- Introduced
- 12/4/2025
- Last activity
- 12/4/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Debbie Dingell
- Cosponsors
- - 0 - 1
- Introduced
- In Committee
A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.
What this bill would do
This resolution affirms support for most-favored-nation drug pricing for patients in the United States. It addresses the issue of United States drug prices being significantly higher than those in other countries. The resolution aims to reduce the cost of prescription drugs for all citizens. It supports aligning U.S. drug prices with the prices found in other developed nations. Additionally, it promotes methods like expanding Medicare drug price negotiation and increasing market competition.
Yes· 3 of 11
Does this lower the price of prescription medicines?+8
The resolution affirms support for aligning U.S. drug prices with the lower prices found in other developed nations.
Would people over 65 be better off under this?+6
Expanding Medicare drug price negotiation directly benefits seniors who rely on these services.
Would retired people be better off under this?+6
The expansion of Medicare negotiation provides direct financial benefits to retirees.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Lower Prescription Drug Costs: The resolution supports policies to align drug pricing in the United States with prices in other developed nations, which aims to reduce the cost of prescription drugs for all citizens (Section 2, Part A).
-
Increased Access to Medicine: By supporting the idea that patients should not be charged more than those in other countries for the exact same drugs, the resolution aims to help citizens have access to high-quality, affordable prescription drugs (Section 1 and Section 3).
-
Expanded Negotiation and Competition: The resolution supports expanding Medicare drug price negotiation and promoting price competition in the drug market to reduce costs (Section 2, Part B).
Potential Negative Impacts for People
- No negative impacts or burdens are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Retirees+6Good For Seniors+6Good For Low Income Households+5Good For Middle Class Households+4Good For Women+2
- Healthcare
- Reduces Prescription Drug Costs+8Improves Healthcare Access+5Increases Medicare Funding+3
- Economy And Finance
- Improves Consumer Protection+5Improves Economic Growth+1
- Social Issues And Justice
- Improves Poverty Reduction+3
- 12/4/2025
- Submitted in House
- Referred to the House Committee on Energy and Commerce.
- 1 Cosponsor added.
Elijah CraneRepublican · Arizona